Clinical trials
Phase 4 Cystic Fibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
87 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 8 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 8 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 7 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 55 |
| Terminated | 15 |
| Unknown status | 7 |
| Recruiting | 5 |
| Active, not recruiting | 3 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| Children's Hospital Medical Center, Cincinnati | 3 |
| Forest Laboratories | 3 |
| Genentech, Inc. | 3 |
| University of Alabama at Birmingham | 3 |
| University of Southern California | 3 |
| AbbVie | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Chris Goss | 2 |
| Emory University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cystic Fibrosis | 87 |
| Exocrine Pancreatic Insufficiency | 9 |
| Pseudomonas Infections | 9 |
| Bone Diseases, Metabolic | 3 |
| Osteoporosis | 3 |
| Lung Diseases | 2 |
| Malnutrition | 2 |
| Pancreatitis, Chronic | 2 |
| Pneumonia | 2 |
| Pneumonia, Bacterial | 2 |
Trials
Showing 51 to 75 of 87. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.